Sun Pharmaceutical Industries Ltd.

Research Sun Pharmaceutical Industries Ltd. (SUNPHARMA.NS) on Bullrun: market cap INR 4.22T, P/E 34.9, dividend yield 0.9%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerSUNPHARMA.NS
ExchangeNSE
CountryIndia
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CurrencyINR
Market capINR 4.22T
P/E34.9
Dividend yield0.9%
Financial periodQ2 2026
RevenueINR 151.84B
Net incomeINR 28.95B
Gross margin80.5%

Valuation Snapshot

latest market cap is INR 4.22T; P/E is 34.9; dividend yield is 0.9%.

Peer valuation comparison

Latest P/E is 34.9x versus a Healthcare sector median of 21.74x (60.5% above).

Latest dividend yield is 0.91% versus a Healthcare sector median of 2.4% (62.1% below).

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	INR 4.22T	34.9	0.9%	16

Dividend history

Latest trailing dividend snapshot: annual dividend/share 16 INR, yield 0.9%.

About Sun Pharmaceutical Industries Ltd.

Related stock research

India stocks India Healthcare stocks A-Z stock index

Other Healthcare stocks

Abbott India Ltd. (ABBOTINDIA.NS) Ajanta Pharmaceuticals Ltd. (AJANTPHARM.NS) Alkem Laboratories Ltd. (ALKEM.NS) Aurobindo Pharma Ltd. (AUROPHARMA.NS) Caplin Point Laboratories Ltd. (CAPLIPOINT.NS) Cipla Ltd. (CIPLA.NS) Cohance Lifesciences Ltd. (COHANCE.NS) Divi's Laboratories Ltd. (DIVISLAB.NS) Dr. Reddy's Laboratories Ltd. (DRREDDY.NS) Emcure Pharmaceuticals Ltd. (EMCURE.NS) Gland Pharma Ltd. (GLAND.NS) Glenmark Pharmaceuticals Ltd. (GLENMARK.NS)

Frequently asked questions

What is Sun Pharmaceutical Industries Ltd.'s market cap?

Sun Pharmaceutical Industries Ltd.'s market capitalization is INR 4.22T.

What is Sun Pharmaceutical Industries Ltd.'s P/E ratio?

Sun Pharmaceutical Industries Ltd.'s price-to-earnings (P/E) ratio is 34.9.

Does Sun Pharmaceutical Industries Ltd. pay a dividend?

Sun Pharmaceutical Industries Ltd. has a dividend yield of 0.9%.

What does Sun Pharmaceutical Industries Ltd. do?

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including neuropsychiatry, cardiology, diabetes, gastroenterology, pain/analgesics, gynecology, ophthalmology, urology, dermatology, respiratory, anti-infectives, oncology, psychiatry, neurology, orthopaedic, nephrology, dental, and nutritionals.